Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Medication and behavioural interventions for tics as reported by parents (n = 295)

From: Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study

    Helpfulness Adverse effects
    Score (−2 to 2) Responded “somewhat helpful” or “very helpful” Score (0 to 3) Responded “moderate” or “severe”
Treatment n (%) Mean ( SD ) n (%) Mean ( SD ) n (%)
Medication           
  Risperidone 77 (27.7) 0.1 (1.3) 30 (39.5) 1.9 (1.1) 48 (63.2)
  Clonidine 73 (26.3) 0.1 (1.1) 30 (41.1) 1.5 (1.1) 34 (46.6)
  Aripiprazole 55 (19.9) 1.0 (1.0 ) 38 (69.1) 0.9 (1.1) 14 (25.5)
  Haloperidol 24 (8.7) −0.1 (1.2) 6 (25.0) 1.9 (1.3) 17 (70.8)
  Sulpiride 13 (4.7) −0.2 (1.0) 2 (15.4) 1.3 (1.4) 6 (46.2)
  Pimozide 7 (2.5) 0.3 (1.3) 3 (42.9) 1.7 (1.4) 4 (57.1)
  Clonazepam 7 (2.5) −0.1 (1.5) 3 (42.9) 2.0 (1.4) 5 (71.4)
  Lorazepam 5 (1.8) 0.2 (1.3) 3 (60.0) 1.6 (1.5) 3 (60.0)
Behavioural interventions for tics 74 (25.9) 0.4 (1.0) 34 (48.6) 0.4 (0.8) 8 (11.4)
  1. Helpfulness scale: −2 = unhelpful – tics got a lot worse; −1 = unhelpful – tics got a bit worse; 0 = tics stayed the same; 1 = somewhat helpful; 2 = very helpful. Adverse effects scale: 0 = none; 1 = mild; 2 = moderate; 3 = severe.